round-table

Tuesday, September 6, 2016

Takeda to develop Zika Vaccine with up to $312 million in funding from US Government

Osaka, Japan, September 1, 2016–Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today  announced that BARDA,  the  Biomedical  Advanced  Research  and  Development  Authority,  has selected Takeda’s Vaccine Business Unit to develop a vaccine to support the Zika response  in  the  US
adultelf.com

wigs for women wigs for women wigs for women wigs for women wigs for women wigs for women wigs for women wigs for women wigs for women wigs for women wigs for women wigs for women wigs for women wigs for women wigs for women wigs for women wigs for women